According to the ACMG/AMP guidelines, this variant is interpreted as a likely pathogenic variant of the SLC12A1 gene, confirming the clinical diagnosis of BS Type 1. This evidence concerns the gene SLC12A1 and idiopathic type 1 diabetes.